Journal Article

DKFZ-2021-01706

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Moderate dose de-escalation of cisplatin-based chemoradiation for HPV-associated oropharyngeal carcinoma : Results of the NRG-HN002 trial[Moderate Dosisdeeskalation der definitiven Cisplatin-basierten Radiochemotherapie für HPV-positive Oropharynxkarzinompatienten : Ergebnisse der NRG-HN002-Studie].

Rühle, A. (First author)DKFZ* ; Nicolay, N. H. (Last author)DKFZ*

2021
Springer Medizin Heidelberg

This record in other databases:  

Please use a persistent id in citations: doi:10.1007/s00066-021-01823-z

Note: 2021 Oct;197(10):950-952 / #EA:E055#LA:E055#

---

Contributing Institute(s):

1. DKTK FR zentral (FR01)
2. E055 KKE Molekulare Radioonkologie (E055)

Research Program(s):

1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2021

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Springer ; Essential Science Indicators ; IF < 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---